US equities |
NVDA $239.85 ▲+0.40% SPCX $173.15 ▲+1.20% MU $1,063.07 ▼-0.08% MRVL $283.41 ▲+4.48% AMD $654.60 ▲+3.62% INTC $113.95 ▼-1.93% SNDK $1,670.05 ▼-2.00% AVGO $378.09 ▲+4.30%
FinancialContent

Olema Pharmaceuticals, Inc. - Common Stock (NQ:OLMA)

7.995 -0.255 (-3.09%)
Delayed Quote Updated: 1:20 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Olema Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Olema Pharmaceuticals Inc. (NASDAQ: OLMA) Near the Top of Equities by Percentage Gain on 2/1
Via Investor Brand Network
News headline image
Eaton Posts Strong Results, Joins Ferrari, Boot Barn And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. 
Via Benzinga
Topics Stocks
News headline image
Olema Oncology Nominates OP-3136, an Orally Bioavailable KAT6 Inhibitor, as a Development Candidate
From Olema Oncology
Via GlobeNewswire
News headline image
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗
Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain. 
Via Investor's Business Daily
Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a Stock Spotlight on 11/28
Via Investor Brand Network
News headline image
Olema Oncology to Present at 42nd Annual J.P. Morgan Healthcare Conference
From Olema Oncology
Via GlobeNewswire
News headline image
$6.9M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying ↗
Although U.S. stocks closed mostly higher on Monday, there were a few notable insider trades. 
Via Benzinga
News headline image
Insiders Buying Walt Disney And 3 Other Stocks ↗
Although U.S. stocks closed higher on Friday, there were a few notable insider trades. 
Via Benzinga
News headline image
Olema Oncology Announces Palazestrant Demonstrates Attractive Combinability with CDK4/6 Inhibitors Ribociclib and Palbociclib in Phase 1b/2 Studies
From Olema Oncology
Via GlobeNewswire
Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a Stock Spotlight on 11/13
Via Investor Brand Network
News headline image
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Olema Oncology
Via GlobeNewswire
News headline image
Olema Oncology to Present New Palazestrant Clinical Data in Combination with CDK4/6 Inhibitors at the 2023 San Antonio Breast Cancer Symposium (SABCS)
From Olema Oncology
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a Stock Spotlight on 11/9
Via Investor Brand Network
Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a Stock Spotlight on 11/8
Via Investor Brand Network
Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a Stock Spotlight on 11/7
Via Investor Brand Network
News headline image
Olema Stock Has Soared 551% This Year. Its CEO Thinks It's Still Undervalued. ↗
The company is working on treatments for breast cancer in a market worth $15 billion, according to the CEO. 
Via Investor's Business Daily
News headline image
Olema Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
From Olema Oncology
Via GlobeNewswire
News headline image
TreeHouse Foods, EchoStar, Hilton Grand Vacations, EchoStar And Other Big Stocks Moving Lower On Monday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 25 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Topics Stocks
News headline image
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Olema Oncology
Via GlobeNewswire
Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a Stock Spotlight on 10/16
Via Investor Brand Network
News headline image
Olema Oncology to Participate in Upcoming Investor Conferences in November
From Olema Oncology
Via GlobeNewswire
News headline image
Olema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results for Palazestrant
From Olema Oncology
Via GlobeNewswire
News headline image
Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
News headline image
Analyst Ratings for Olema Pharmaceuticals ↗
 
Via Benzinga
News headline image
Olema Oncology Appoints Oncology Biotech Executive Scott Garland to Board of Directors
Mr. Garland brings significant industry expertise with a long track record of successful launches 
From Olema Oncology
Via GlobeNewswire
News headline image
Olema Oncology Announces Phase 2 Monotherapy Clinical Results to be Presented at the 2023 ESMO Congress
From Olema Oncology
Via GlobeNewswire
News headline image
Olema Oncology KAT6 Inhibitor Compounds Demonstrate Potent Anti-Tumor Activity
Preclinical data to be presented at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 
From Olema Oncology
Via GlobeNewswire
News headline image
Olema Oncology Announces Expansion of Collaboration Agreement with Novartis
From Olema Oncology
Via GlobeNewswire
News headline image
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Olema Oncology
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >